nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Absence of the X1st gene from the late replicating isodicentric X chromosome in myelodysplasia
|
Oscier, D. |
|
1994 |
18 |
S |
p. 45- 1 p. |
artikel |
2 |
Acute myeloblastic leukemia (AML) with trilineage myelodysplasia (TMD+): characteristics and prognosis
|
Rajić, Nebojša |
|
1994 |
18 |
S |
p. 37- 1 p. |
artikel |
3 |
Affection of CD 34-positive progenitor cells by chromosome abnormalities and karyotype evolution in a case of secondary MDS
|
Haase, Detlef |
|
1994 |
18 |
S |
p. 44- 1 p. |
artikel |
4 |
Allogeneic bone marrow transplantation for MDS: One institution's experience with one regimen
|
Ratanatharathorn, Voravit |
|
1994 |
18 |
S |
p. 66- 1 p. |
artikel |
5 |
Allogeneic bone marrow transplantation in childhood chronic myelomonocytic leukemia. A report on behalf of the European Working group on childhood myelodysplastic syndromes (EWOG-MDS)
|
van 't Veer-Korthof, E.T. |
|
1994 |
18 |
S |
p. 25- 1 p. |
artikel |
6 |
Allogeneic marrow transplantation for myelodysplastic syndrome (MDS) using unrelated donors (URD)
|
Anderson, J.E. |
|
1994 |
18 |
S |
p. 26- 1 p. |
artikel |
7 |
Allogenic bone marrow transplantation (BMT) in RAEB/RAEBt patients-optimal time (model II)
|
Popović, Stevan |
|
1994 |
18 |
S |
p. 66- 1 p. |
artikel |
8 |
An association between telomere shortening and disease evolution patterns in MDS
|
Ohyashiki, Kazuma |
|
1994 |
18 |
S |
p. 9- 1 p. |
artikel |
9 |
ANLL following autologous bone marrow transplantation
|
Roman-Unfer, Susan |
|
1994 |
18 |
S |
p. 46- 1 p. |
artikel |
10 |
A phase III trial of subcutaneous administration of rhG-CSF in the myelodysplastic syndromes
|
Yoshida, Y. |
|
1994 |
18 |
S |
p. 17- 1 p. |
artikel |
11 |
A randomized trial of hydroxyuea (HY) versus VP16 in advanced adult chronic myelomonocytic leukemia
|
Wattel, E. |
|
1994 |
18 |
S |
p. 21- 1 p. |
artikel |
12 |
A randomized trial of two doses of IL-3 in patients with MDS
|
Stone, R.M. |
|
1994 |
18 |
S |
p. 18- 1 p. |
artikel |
13 |
Atypical chronic myeloid leukeamia. Is it a separate entity?
|
Oscier, D.G. |
|
1994 |
18 |
S |
p. 37- 1 p. |
artikel |
14 |
A unique karyotype with low level mosaicism: 45, X, -Y, del(20q)/46, XY, del(20q) in a myelodysplastic syndrome surfaces using FISH technology
|
David, K. |
|
1994 |
18 |
S |
p. 43- 1 p. |
artikel |
15 |
Author index
|
|
|
1994 |
18 |
S |
p. I-III nvt p. |
artikel |
16 |
Autoimmune phenomena in myelodysplastic syndromes: Response to immunosuppressive therapy
|
Enright, Helen |
|
1994 |
18 |
S |
p. 54- 1 p. |
artikel |
17 |
5-Azacytidine in myelodysplastic syndromes (MDS): The experience at mount Sinai Hospital, New York
|
Silverman, Lewis R. |
|
1994 |
18 |
S |
p. 21- 1 p. |
artikel |
18 |
Bone marrow transplantation for myelodysplastic syndromes and secondary acute myelocytic leukemia
|
Castro-Malaspina, H. |
|
1994 |
18 |
S |
p. 65- 1 p. |
artikel |
19 |
Cell biology and programmed cell death in MDS
|
Yoshida, Yataro |
|
1994 |
18 |
S |
p. 5- 1 p. |
artikel |
20 |
Characteristics of the hemopoietic abnormalities after chronic exposure to benzene
|
Ruiz, M.A. |
|
1994 |
18 |
S |
p. 29- 1 p. |
artikel |
21 |
Childhood MDS treated with AML regimens
|
Hasle, Henrik |
|
1994 |
18 |
S |
p. 25- 1 p. |
artikel |
22 |
Chromosomal abnormalities in myelodisplastic syndromes (MDS) in the Mexican population
|
Arana Trejo, Rosa Ma. |
|
1994 |
18 |
S |
p. 45- 1 p. |
artikel |
23 |
Chronic myelomonocytic leukemia (CMML) in childhood
|
Niemeyer, C. |
|
1994 |
18 |
S |
p. 6- 1 p. |
artikel |
24 |
Clinical and laboratory analysis of patients with deletions of part of chromosome 5q
|
Wos, E. |
|
1994 |
18 |
S |
p. 43- 1 p. |
artikel |
25 |
Clinical trials of G-CSF and erythropoietin (Epo) in MDS
|
Greenberg, Peter L. |
|
1994 |
18 |
S |
p. 21- 1 p. |
artikel |
26 |
Cloning and characterization of the t(5; 12) translocation breakpoint associated with chronic myelomonocytic leukemia (CMML)
|
Golub, Todd |
|
1994 |
18 |
S |
p. 13- 1 p. |
artikel |
27 |
Comparative risk factor analysis in Japanese patients with myelodysplastic syndromes
|
Ohyashiki, Kazuma |
|
1994 |
18 |
S |
p. 40- 1 p. |
artikel |
28 |
Comparative study of the prognostic value for survival and leukemic transformation of three different scoring systems in MDS: Experience of the Spanish cooperative group on MDS
|
Sanz, G.F. |
|
1994 |
18 |
S |
p. 38- 1 p. |
artikel |
29 |
Comparison between the FAB system and three prognostic scoring systems in 245 untreated patients with de novo MDS. The lille experience
|
Morel, P. |
|
1994 |
18 |
S |
p. 38- 1 p. |
artikel |
30 |
Comparison of different scoring systems for risk analysis in MDS
|
Aul, C. |
|
1994 |
18 |
S |
p. 39- 1 p. |
artikel |
31 |
Comparison of four categorized risk scoring systems for analyzing outcome in advanced MDS
|
Greenberg, P. |
|
1994 |
18 |
S |
p. 40- 1 p. |
artikel |
32 |
Comparison of four prognostic scores for survival and transformation in MDS
|
Mufti, Ghulam J. |
|
1994 |
18 |
S |
p. 6- 1 p. |
artikel |
33 |
Comparison of scoring systems for prognosis in MDS
|
Kruger, A. |
|
1994 |
18 |
S |
p. 40- 1 p. |
artikel |
34 |
Concordance/discordance in assessing leukemic evolution between three different scoring systems in MDS: The experience of the Spanish cooperative group on MDS
|
Lopez, F. |
|
1994 |
18 |
S |
p. 38- 1 p. |
artikel |
35 |
Concordance/discordance in assessing survival between three different scoring systems in MDS: The experience of the Spanish cooperative group on MDS
|
Sanz, G.F. |
|
1994 |
18 |
S |
p. 38- 1 p. |
artikel |
36 |
Cytogenetic analysis in fifty patients with myelodysplastic syndrome
|
Fernandez, Teresa S. |
|
1994 |
18 |
S |
p. 44- 1 p. |
artikel |
37 |
Cytokine level in the serum of AML and MDS patients
|
Depaoli, Lorella |
|
1994 |
18 |
S |
p. 53- 1 p. |
artikel |
38 |
Cytomorphological results and dysplastic features as prognostic factors in 41 cases with acute myeloid leukemia (AML) and translocation
|
Haferlach, T. |
|
1994 |
18 |
S |
p. 45- 1 p. |
artikel |
39 |
Differential diagnosis of myelodysplasia (MDS) and erythroleukemia (FAB:M6): A multicenter I.G.C.I. trial
|
Krieger, O. |
|
1994 |
18 |
S |
p. 36- 1 p. |
artikel |
40 |
Dysmegakaryopoiesis versus amegakaryopiesis in patients with primary MDS
|
Yavorkovsky, Leonid L. |
|
1994 |
18 |
S |
p. 33- 1 p. |
artikel |
41 |
Dysplastic hematopoiesis following orthotopic liver transplantation: Comparison with similar changes in HIV-infection and primary myelodysplasia
|
Clatch, Richard J. |
|
1994 |
18 |
S |
p. 30- 1 p. |
artikel |
42 |
Effective erythroid output and reticulocyte to red cell maturation in MDS patients measured using the Technicon H3 analyser
|
Bowen, David T. |
|
1994 |
18 |
S |
p. 34- 1 p. |
artikel |
43 |
Epidemiology of MDS in childhood
|
Hasle, Henrik |
|
1994 |
18 |
S |
p. 1- 1 p. |
artikel |
44 |
Erythropoietin-independent erythroid progenitors in patients with sideroblastic anaemia and thrombocytosis
|
Oscler, D.G. |
|
1994 |
18 |
S |
p. 37- 1 p. |
artikel |
45 |
Erythropoietin levels and the medullary hematopoietic pool of myelodysplastic syndrome
|
Kageyama, Takashi |
|
1994 |
18 |
S |
p. 37- 1 p. |
artikel |
46 |
Evaluation of the distributions of cellular marrow by using magnetic resonance imaging(MRI) in patients with myelodysplastic syndromes and aplastic anemia
|
Tsushima, Hideki |
|
1994 |
18 |
S |
p. 34- 1 p. |
artikel |
47 |
Exposure to occupational and environmental factors in MDS. Preliminary results of a case control study
|
Nisse, C. |
|
1994 |
18 |
S |
p. 1- 1 p. |
artikel |
48 |
Expression of the EVI-1 gene in myelodysplastic syndromes
|
Dreyfus, F. |
|
1994 |
18 |
S |
p. 50- 1 p. |
artikel |
49 |
Extremely high incidence of apoptosis may explain ineffective hematopoiesis in myelodysplastic syndromes (MDS)
|
Raza, A. |
|
1994 |
18 |
S |
p. 13- 1 p. |
artikel |
50 |
Fish and “Fiction” analysis of chromosome 7 in MDS : a study on 99 cases
|
Soenen, V. |
|
1994 |
18 |
S |
p. 43- 1 p. |
artikel |
51 |
Frequency and prognostic value of dysmyelopoiesis in 114 patients with de novo acute myeloid leukemia (AML) in an ongoing study
|
Haferlach, T. |
|
1994 |
18 |
S |
p. 36- 1 p. |
artikel |
52 |
Genetic lesions and clinical outcome in myelodysplasia (MDS)
|
Oscier, David |
|
1994 |
18 |
S |
p. 50- 1 p. |
artikel |
53 |
Growth factor (GF) augmentation of intensive chemotherapy for MDS and AML following MDS
|
Gore, Steven D. |
|
1994 |
18 |
S |
p. 25- 1 p. |
artikel |
54 |
High remission rate, short remission duration in patients with refractory anemia with excess blasts (RAEB) or RAEB in transformation (RAEB-t) given acute myelogenous leukemia (AML)-type chemotherapy
|
Estey, Elihu H. |
|
1994 |
18 |
S |
p. 21- 1 p. |
artikel |
55 |
Histological findings in fifty patients with primary myelodysplastic syndromes
|
Souza, J.M. |
|
1994 |
18 |
S |
p. 36- 1 p. |
artikel |
56 |
Hypocellular AML: A clinical entity with hematological features distinct from MDS
|
Nagai, Kazuhiro |
|
1994 |
18 |
S |
p. 35- 1 p. |
artikel |
57 |
Immunophenotype and genotype of MDS in acute transformation
|
Chen, Y.C. |
|
1994 |
18 |
S |
p. 35- 1 p. |
artikel |
58 |
Impact on survival and leukemic transformation of in vitro growth pattern of granulocyte-macrophage progenitors (CFU-GM) in MDS
|
Garcia, M. |
|
1994 |
18 |
S |
p. 54- 1 p. |
artikel |
59 |
Increased expression of bcl-2 protein in the bone marrow biopsies of patients with primary MDS
|
Lambertenghi Deliliers, G. |
|
1994 |
18 |
S |
p. 50- 1 p. |
artikel |
60 |
Intensive chemotherapy with or without G-CSF in high risk myelodysplastic syndromes (MDS) or acute leukemia (AL) evolving from MDS: Randomized clinical study
|
Bernasconi, C. |
|
1994 |
18 |
S |
p. 65- 1 p. |
artikel |
61 |
In vitro effects of IL-2 and LAK cells on clonogenic potential, blast cell proliferation and cytokine release of MDS bone marrow cells
|
Cortelezzi, A. |
|
1994 |
18 |
S |
p. 18- 1 p. |
artikel |
62 |
Karyotype at diagnosis, subsequent leukemic transformation and survival in MDS
|
Musilová, J. |
|
1994 |
18 |
S |
p. 44- 1 p. |
artikel |
63 |
Lack of c-kit point mutations in patients with myelodysplastic syndromes and other hematopoietic disorders
|
deCastro, Carlos M. |
|
1994 |
18 |
S |
p. 49- 1 p. |
artikel |
64 |
MDS and AML with 17p deletion are associated to specific dysgranulopoiesis and a high incidence of p53 mutations
|
Preudhomme, C. |
|
1994 |
18 |
S |
p. 9- 1 p. |
artikel |
65 |
Microdeletion at the acetylcholinesterase locus at 7q22 associated with myelodysplasia and acute myeloid leukaemia
|
Stephenson, J. |
|
1994 |
18 |
S |
p. 13- 1 p. |
artikel |
66 |
Mixed myelodysplastic and myeloproliferative syndromes
|
Neuwirtová, R. |
|
1994 |
18 |
S |
p. 36- 1 p. |
artikel |
67 |
Molecular analysis of chromosome 20q deletions associated with myeloproliferative disorders and myelodysplastic syndromes
|
Asimakopoulos, Fotios A. |
|
1994 |
18 |
S |
p. 43- 1 p. |
artikel |
68 |
Multi-dimensional flow cytometric antigenic comparison of bone marrow from normal, AML and MDS patients
|
Wells, Denise A. |
|
1994 |
18 |
S |
p. 5- 1 p. |
artikel |
69 |
Multiparameter flow cytometry in RAEB patients treated with GM-CSF and low-dose ARA-c
|
Hokland, Peter |
|
1994 |
18 |
S |
p. 17- 1 p. |
artikel |
70 |
Myelodysplasia and its discontents: A patient's perspective
|
Fleischman, Suzanne |
|
1994 |
18 |
S |
p. 57- 1 p. |
artikel |
71 |
Myelodysplastic syndrome in young adults aged 15–35 years. A report on 57 cases
|
Cermak, Jaroslav |
|
1994 |
18 |
S |
p. 34- 1 p. |
artikel |
72 |
Myelodysplastic syndrome (MDS) and cranial nerve paralysis after perchlorethylene (PER) exposure
|
Keiser, Georg |
|
1994 |
18 |
S |
p. 29- 1 p. |
artikel |
73 |
Myelodysplastic syndromes(MDS): Analysis of prognostic factors and scoring systems
|
Souto, E.X. |
|
1994 |
18 |
S |
p. 35- 1 p. |
artikel |
74 |
Myelomonocytic antigen abnormalities on neutrophils and monocytes in myelodysplastic syndromes
|
Bernier, M. |
|
1994 |
18 |
S |
p. 5- 1 p. |
artikel |
75 |
Occupational exposure and cytogenetics in MDS/AML
|
Wong, K.F. |
|
1994 |
18 |
S |
p. 1- 1 p. |
artikel |
76 |
P. glycoprotein (PGP) expression and response to intensive chemotherapy and low dose AraC in myelodysplastic syndromes (MDS). A report on 66 cases
|
Wattel, E. |
|
1994 |
18 |
S |
p. 65- 1 p. |
artikel |
77 |
Phase III multicenter randomized trial in RAEB patients of more than 60 years of age: Ara-C 3mg/m2 versus symptomatic treatment
|
Chomienne, C. |
|
1994 |
18 |
S |
p. 22- 1 p. |
artikel |
78 |
P53 mutations are a strong prognostic factor of response to chemotherapy and survival in myelodysplastic syndromes (MDS)
|
Wattel, E. |
|
1994 |
18 |
S |
p. 49- 1 p. |
artikel |
79 |
Prediction of 18 months survival in patients with primary myelodysplastic syndrome: a regression model and scoring system based on the combination of chromosome findings and the bournemouth score
|
Parlier, V. |
|
1994 |
18 |
S |
p. 39- 1 p. |
artikel |
80 |
Prediction of response to G-CSF and epo treatment for the anaemia of myelodysplastic syndromes (MDS)
|
Hellström-Lindberg, Eva |
|
1994 |
18 |
S |
p. 53- 1 p. |
artikel |
81 |
Pre-leukemic disorders in childhood
|
Lopes, L.F. |
|
1994 |
18 |
S |
p. 33- 1 p. |
artikel |
82 |
Procainamide-associated blood dyscrasias: A 10-year retrospective report
|
Uprichard, Andrew C.G. |
|
1994 |
18 |
S |
p. 29- 1 p. |
artikel |
83 |
Prognosis scoring system in refractory anemia with excess of blast (RAEB)
|
Chevret, S. |
|
1994 |
18 |
S |
p. 6- 1 p. |
artikel |
84 |
Prognostic factors in myelodysplastic syndromes: a cytologic, histologic and cytogenetic study
|
Souza, J.M. |
|
1994 |
18 |
S |
p. 35- 1 p. |
artikel |
85 |
Prognostic importance of type II blasts in refractory anemia with excess of blasts (RAEB). A report on 91 cases
|
Guerci, A.P. |
|
1994 |
18 |
S |
p. 39- 1 p. |
artikel |
86 |
Prognostic value of c- MPL expression in myelodysplastic syndromes
|
Bouscary, D. |
|
1994 |
18 |
S |
p. 50- 1 p. |
artikel |
87 |
Prognostic value of histological parameters and CD34 reactivity in the bone marrow biopsies of MDS patients
|
Lambertenghi Deliliers, G. |
|
1994 |
18 |
S |
p. 39- 1 p. |
artikel |
88 |
Recombinant human erythropoietin (Rhu-Epo) therapy in low grade myelodysplastic syndromes: Role of cytokines
|
Di Stefano, M. |
|
1994 |
18 |
S |
p. 18- 1 p. |
artikel |
89 |
Refractory cytopenia and marrow eosinophilia with intranuclear charcot leyden crystals
|
Wong, K.F. |
|
1994 |
18 |
S |
p. 33- 1 p. |
artikel |
90 |
Relationship between hematological characteristics and granulocyte-macrophage colony formation (CFU-GM) in MDS
|
Garcia, M. |
|
1994 |
18 |
S |
p. 53- 1 p. |
artikel |
91 |
Secondary acute myeloid leukemia as a result of chemotherapy for soft tissue sarcoma
|
Varterasian, Mary |
|
1994 |
18 |
S |
p. 29- 1 p. |
artikel |
92 |
Secondary myelodysplastic syndrome following myeloma therapy
|
Irněný, M. |
|
1994 |
18 |
S |
p. 30- 1 p. |
artikel |
93 |
Serumconcentrations of interleukin-6 soluble receptor (IL-6sR) in patients with MDS
|
Herold, M. |
|
1994 |
18 |
S |
p. 18- 1 p. |
artikel |
94 |
Should auer rods be used in the classification of myelodysplastic syndromes (MDS)?
|
Seymour, J.F. |
|
1994 |
18 |
S |
p. 5- 1 p. |
artikel |
95 |
Spontaneous cytokine production in aplastic anemia and refractiory anemia
|
Koike, M. |
|
1994 |
18 |
S |
p. 53- 1 p. |
artikel |
96 |
Study of clonality and evolution of myelodysplastic syndromes using fluorescence in situ hybridization
|
Abruzzese, E. |
|
1994 |
18 |
S |
p. 44- 1 p. |
artikel |
97 |
Synergistic effect of G-CSF and epo on the anaemia in patients with MDS. Evidence for increased erythropoietic effectiveness rather than expansion
|
Hellström-Lindberg, E. |
|
1994 |
18 |
S |
p. 17- 1 p. |
artikel |
98 |
The erythropoietin receptor gene in myelodysplastic syndromes and other stem cell disorders: A different gene in an MDS patient
|
Mittelman, Moshe |
|
1994 |
18 |
S |
p. 49- 1 p. |
artikel |
99 |
The impact of different cytogenetic subgroups on survival of 203 patients with MDS
|
Vallespi, T. |
|
1994 |
18 |
S |
p. 46- 1 p. |
artikel |
100 |
The management of chronic myelomonocytic leukaemia
|
Oscier, D.G. |
|
1994 |
18 |
S |
p. 25- 1 p. |
artikel |
101 |
The MIP-1-α/RANTES receptor gene in the myelodysplastic syndromes
|
Berger, Mark S. |
|
1994 |
18 |
S |
p. 49- 1 p. |
artikel |
102 |
The 5q-syndrome: Clinical course of 12 patients
|
Lesseve, J.F. |
|
1994 |
18 |
S |
p. 45- 1 p. |
artikel |
103 |
Therapeutic trial of combination of rGM-CSF, androgen therapy and low dose cytosine arabinoside (Ara-C) in RAEB and RAEB-t
|
Guerci, A.P. |
|
1994 |
18 |
S |
p. 61- 1 p. |
artikel |
104 |
Treatment of acute leukemia arising from myelodysplastic syndromes with oral idarubicin, etoposide, and 6-thioguanine
|
Montillo, M. |
|
1994 |
18 |
S |
p. 61- 1 p. |
artikel |
105 |
Treatment of advanced primary myelodysplastic syndromes with AML-type chemotherapy: Results in 76 patients
|
Aul, C. |
|
1994 |
18 |
S |
p. 22- 1 p. |
artikel |
106 |
Treatment of “high risk” myelodysplastic syndromes (MDS) with idarubicin and cytosine arabinoside, supported by granulocyte-macrophage colony stimulating factor (GM-CSF)
|
Economopoulos, T. |
|
1994 |
18 |
S |
p. 65- 1 p. |
artikel |
107 |
Treatment with alpha-lymphoblastoid interferon (wellferon) in high risk myelodysplastic syndromes (HR-MDS)
|
Petti, M.C. |
|
1994 |
18 |
S |
p. 61- 1 p. |
artikel |
108 |
Trilineage dysplasia in de novo AML: Relation to MDS
|
Tomonaga, Masao |
|
1994 |
18 |
S |
p. 34- 1 p. |
artikel |
109 |
Type IV myeloblasts or hypogranular promyelocytes?
|
Wong, K.F. |
|
1994 |
18 |
S |
p. 33- 1 p. |
artikel |
110 |
Update on juvenile CML: Pathogenesis and treatment
|
Emanuel, Peter D. |
|
1994 |
18 |
S |
p. 22- 1 p. |
artikel |
111 |
Very low dose GM-CSF (0.5 or 0.25 μg/kg/d) in MDS. A report on 35 cases
|
Rose, C. |
|
1994 |
18 |
S |
p. 17- 1 p. |
artikel |